| 1 |
27404795 | Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes. | 2017 Jan |
7 |
| 2 |
27555113 | Histone Deacetylase Inhibitor Vorinostat (SAHA) Suppresses IL-1β-Induced Matrix Metallopeptidase-13 Expression by Inhibiting IL-6 in Osteoarthritis Chondrocyte. | 2016 Oct |
6 |
| 3 |
25636517 | The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. | 2015 Apr 10 |
4 |
| 4 |
24107356 | Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes. | 2013 Dec |
2 |
| 5 |
20421217 | Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. | 2010 Aug |
2 |
| 6 |
19711464 | Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium. | 2009 Dec 1 |
3 |
| 7 |
12531799 | Molecular sequelae of histone deacetylase inhibition in human malignant B cells. | 2003 May 15 |
2 |